Iambic Therapeutics

Iambic Therapeutics is a biotechnology company based in La Jolla, California, specializing in AI-driven drug discovery and development. Founded in 2019, the company focuses on addressing unmet patient needs by utilizing advanced AI algorithms to tackle complex challenges in drug design. Iambic's platform integrates physics-based AI models for protein structure prediction and holistic drug design, enabling efficient exploration of chemical structures and the development of novel therapeutics. The company operates a closed-loop, automated process for biological and chemical experimentation, allowing for rapid design-make-test cycles. This approach significantly accelerates the drug development timeline. Iambic's team includes experts in AI and drug development, featuring Frances H. Arnold, a Nobel Laureate in Chemistry. With a total of $206.23 million raised in funding, Iambic is advancing an internal pipeline of clinical assets aimed at developing innovative therapeutics across various target classes.